glp-1 hub podcast As a registered dietitian (and user myself), I've learned that having GLP-1 Hub Podcast: An Introduction

One of the three lead scientists, Dr Julia Moore-Vogel, joined me to discuss the LoCITT-T Trial

Pablo de la Cueva ha participado como asesor y/o investigador y/o ponente con los siguientes laboratorios farmacuticos: Abbvie, Almirall, BMS, Boehringer-Ingelheim, Celgene, Janssen Cilag, LEO Pharma, Lilly, MSD, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi y UCB

GLP-1 RAs demonstrate well-established anti-inflammatory and metabolic regulatory properties that may benefit autoimmune thyroid disorders through multiple mechanisms

*These findings show an association between stopping GLP-1 RAs and these outcomes, but not a causation